Emily Days
Impact in
-
- Neuroscience and Neuropharmacology Research
- Neuropeptides and Animal Physiology
- Molecular Biology top 10%
- Receptor Mechanisms and Signaling
- Ion channel regulation and function
- Nicotinic Acetylcholine Receptors Study
Papers in
-
- Neuroscience and Neuropharmacology Research 12
- Neuropeptides and Animal Physiology 3
-
- Ion channel regulation and function 16
- Receptor Mechanisms and Signaling 11
- Pharmacological Receptor Mechanisms and Effects 4
- Nicotinic Acetylcholine Receptors Study 3
- Co-authors
- C. David WeaverCraig W. LindsleyColleen M. NiswenderP. Jeffrey ConnAlice L. RodriguezCarrie K. JonesPaige N. VinsonJerod S. Denton
- Journals
- Molecular Pharmacology (7 papers)ACS Chemical Neuroscience (3 papers)ACS Medicinal Chemistry Letters (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Assay and Drug Development Technologies (2 papers)
- Partner nations
- United StatesRussiaBelgium
In The Last Decade
Emily Days
32 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 90
- Cellular and Molecular Neuroscience 822
- Molecular Biology 944
- Insect Science 84
- Biological Psychiatry 17
- Neurology 39
Countries citing papers authored by Emily Days
This map shows the geographic impact of Emily Days's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Days with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Days more than expected).
Fields of papers citing papers by Emily Days
This network shows the impact of papers produced by Emily Days. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Days. The network helps show where Emily Days may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emily Days, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 5 | |
| 3 | 2023 | 22 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 10 | |
| 6 | 2018 | 45 | |
| 7 | 2017 | 20 | |
| 8 | 2016 | 60 | |
| 9 | 2014 | 42 | |
| 10 | 2014 | 11 | |
| 11 | 2013 | 23 | |
| 12 | 2013 | 125 | |
| 13 | 2012 | 21 | |
| 14 | Allosteric Modulators of Metabotropic Glutamate Receptor 5 for Treatment of Schizophrenia | 2011 | 1 |
| 15 | 2011 | 99 | |
| 16 | 2011 | 33 | |
| 17 | 2010 | 147 | |
| 18 | 2008 | 119 | |
| 19 | 2008 | 161 | |
| 20 | 2005 | 21 |
About Emily Days
Emily Days is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology, Cardiology and Cardiovascular Medicine, Emergency Medicine and Spectroscopy, having authored 34 papers that have together received 1.3k indexed citations. Recurring topics across this work include Ion channel regulation and function (16 papers), Neuroscience and Neuropharmacology Research (12 papers), Receptor Mechanisms and Signaling (11 papers), Cardiac electrophysiology and arrhythmias (8 papers), Pharmacological Receptor Mechanisms and Effects (4 papers), Diabetes Treatment and Management (3 papers), Nicotinic Acetylcholine Receptors Study (3 papers) and Neuropeptides and Animal Physiology (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (822 citations), Molecular Biology (944 citations), Insect Science (84 citations), Biological Psychiatry (17 citations) and Neurology (39 citations). Emily Days has collaborated with scholars based in United States, Russia and Belgium. Frequent co-authors include C. David Weaver, Craig W. Lindsley, Colleen M. Niswender, P. Jeffrey Conn, Alice L. Rodriguez, Carrie K. Jones, Paige N. Vinson, Jerod S. Denton, Joy E. Marlo and Richard D. Williams. Their work appears in journals such as Molecular Pharmacology, ACS Chemical Neuroscience, ACS Medicinal Chemistry Letters, Bioorganic & Medicinal Chemistry Letters and Assay and Drug Development Technologies.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.